Global Bacterial Vaginosis OTC Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bacterial Vaginosis OTC Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bacterial Vaginosis OTC Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bacterial Vaginosis OTC Drug by Country/Region, 2017, 2022 & 2028

2.2 Bacterial Vaginosis OTC Drug Segment by Type

2.2.1 Pill

2.2.2 Gel

2.2.3 Cream

2.2.4 Other

2.3 Bacterial Vaginosis OTC Drug Sales by Type

2.3.1 Global Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Bacterial Vaginosis OTC Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bacterial Vaginosis OTC Drug Sale Price by Type (2017-2022)

2.4 Bacterial Vaginosis OTC Drug Segment by Application

2.4.1 Pharmacy

2.4.2 On-line

2.4.3 Other

2.5 Bacterial Vaginosis OTC Drug Sales by Application

2.5.1 Global Bacterial Vaginosis OTC Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Bacterial Vaginosis OTC Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bacterial Vaginosis OTC Drug Sale Price by Application (2017-2022)

3 Global Bacterial Vaginosis OTC Drug by Company

3.1 Global Bacterial Vaginosis OTC Drug Breakdown Data by Company

3.1.1 Global Bacterial Vaginosis OTC Drug Annual Sales by Company (2020-2022)

3.1.2 Global Bacterial Vaginosis OTC Drug Sales Market Share by Company (2020-2022)

3.2 Global Bacterial Vaginosis OTC Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Bacterial Vaginosis OTC Drug Revenue by Company (2020-2022)

3.2.2 Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company (2020-2022)

3.3 Global Bacterial Vaginosis OTC Drug Sale Price by Company

3.4 Key Manufacturers Bacterial Vaginosis OTC Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bacterial Vaginosis OTC Drug Product Location Distribution

3.4.2 Players Bacterial Vaginosis OTC Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bacterial Vaginosis OTC Drug by Geographic Region

4.1 World Historic Bacterial Vaginosis OTC Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Bacterial Vaginosis OTC Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bacterial Vaginosis OTC Drug Annual Revenue by Geographic Region

4.2 World Historic Bacterial Vaginosis OTC Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Bacterial Vaginosis OTC Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bacterial Vaginosis OTC Drug Annual Revenue by Country/Region

4.3 Americas Bacterial Vaginosis OTC Drug Sales Growth

4.4 APAC Bacterial Vaginosis OTC Drug Sales Growth

4.5 Europe Bacterial Vaginosis OTC Drug Sales Growth

4.6 Middle East & Africa Bacterial Vaginosis OTC Drug Sales Growth

5 Americas

5.1 Americas Bacterial Vaginosis OTC Drug Sales by Country

5.1.1 Americas Bacterial Vaginosis OTC Drug Sales by Country (2017-2022)

5.1.2 Americas Bacterial Vaginosis OTC Drug Revenue by Country (2017-2022)

5.2 Americas Bacterial Vaginosis OTC Drug Sales by Type

5.3 Americas Bacterial Vaginosis OTC Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bacterial Vaginosis OTC Drug Sales by Region

6.1.1 APAC Bacterial Vaginosis OTC Drug Sales by Region (2017-2022)

6.1.2 APAC Bacterial Vaginosis OTC Drug Revenue by Region (2017-2022)

6.2 APAC Bacterial Vaginosis OTC Drug Sales by Type

6.3 APAC Bacterial Vaginosis OTC Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bacterial Vaginosis OTC Drug by Country

7.1.1 Europe Bacterial Vaginosis OTC Drug Sales by Country (2017-2022)

7.1.2 Europe Bacterial Vaginosis OTC Drug Revenue by Country (2017-2022)

7.2 Europe Bacterial Vaginosis OTC Drug Sales by Type

7.3 Europe Bacterial Vaginosis OTC Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bacterial Vaginosis OTC Drug by Country

8.1.1 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type

8.3 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bacterial Vaginosis OTC Drug

10.3 Manufacturing Process Analysis of Bacterial Vaginosis OTC Drug

10.4 Industry Chain Structure of Bacterial Vaginosis OTC Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bacterial Vaginosis OTC Drug Distributors

11.3 Bacterial Vaginosis OTC Drug Customer

12 World Forecast Review for Bacterial Vaginosis OTC Drug by Geographic Region

12.1 Global Bacterial Vaginosis OTC Drug Market Size Forecast by Region

12.1.1 Global Bacterial Vaginosis OTC Drug Forecast by Region (2023-2028)

12.1.2 Global Bacterial Vaginosis OTC Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bacterial Vaginosis OTC Drug Forecast by Type

12.7 Global Bacterial Vaginosis OTC Drug Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Bacterial Vaginosis OTC Drug Product Offered

13.1.3 Bayer Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Bacterial Vaginosis OTC Drug Product Offered

13.2.3 Pfizer Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Bacterial Vaginosis OTC Drug Product Offered

13.3.3 Sanofi Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Piramal

13.4.1 Piramal Company Information

13.4.2 Piramal Bacterial Vaginosis OTC Drug Product Offered

13.4.3 Piramal Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Piramal Main Business Overview

13.4.5 Piramal Latest Developments

13.5 Abbott

13.5.1 Abbott Company Information

13.5.2 Abbott Bacterial Vaginosis OTC Drug Product Offered

13.5.3 Abbott Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abbott Main Business Overview

13.5.5 Abbott Latest Developments

13.6 Galderma

13.6.1 Galderma Company Information

13.6.2 Galderma Bacterial Vaginosis OTC Drug Product Offered

13.6.3 Galderma Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Galderma Main Business Overview

13.6.5 Galderma Latest Developments

13.7 Mission

13.7.1 Mission Company Information

13.7.2 Mission Bacterial Vaginosis OTC Drug Product Offered

13.7.3 Mission Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mission Main Business Overview

13.7.5 Mission Latest Developments

13.8 Alkem

13.8.1 Alkem Company Information

13.8.2 Alkem Bacterial Vaginosis OTC Drug Product Offered

13.8.3 Alkem Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Alkem Main Business Overview

13.8.5 Alkem Latest Developments

13.9 Xiuzheng

13.9.1 Xiuzheng Company Information

13.9.2 Xiuzheng Bacterial Vaginosis OTC Drug Product Offered

13.9.3 Xiuzheng Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Xiuzheng Main Business Overview

13.9.5 Xiuzheng Latest Developments

13.10 Teva

13.10.1 Teva Company Information

13.10.2 Teva Bacterial Vaginosis OTC Drug Product Offered

13.10.3 Teva Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Main Business Overview

13.10.5 Teva Latest Developments

13.11 Perrigo

13.11.1 Perrigo Company Information

13.11.2 Perrigo Bacterial Vaginosis OTC Drug Product Offered

13.11.3 Perrigo Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Perrigo Main Business Overview

13.11.5 Perrigo Latest Developments

13.12 West-Ward

13.12.1 West-Ward Company Information

13.12.2 West-Ward Bacterial Vaginosis OTC Drug Product Offered

13.12.3 West-Ward Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 West-Ward Main Business Overview

13.12.5 West-Ward Latest Developments

13.13 HPGC

13.13.1 HPGC Company Information

13.13.2 HPGC Bacterial Vaginosis OTC Drug Product Offered

13.13.3 HPGC Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 HPGC Main Business Overview

13.13.5 HPGC Latest Developments

13.14 Yunnan Baiyao

13.14.1 Yunnan Baiyao Company Information

13.14.2 Yunnan Baiyao Bacterial Vaginosis OTC Drug Product Offered

13.14.3 Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Yunnan Baiyao Main Business Overview

13.14.5 Yunnan Baiyao Latest Developments

13.15 Starpharma

13.15.1 Starpharma Company Information

13.15.2 Starpharma Bacterial Vaginosis OTC Drug Product Offered

13.15.3 Starpharma Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Starpharma Main Business Overview

13.15.5 Starpharma Latest Developments

13.16 Novel

13.16.1 Novel Company Information

13.16.2 Novel Bacterial Vaginosis OTC Drug Product Offered

13.16.3 Novel Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Novel Main Business Overview

13.16.5 Novel Latest Developments

13.17 Edenvridge

13.17.1 Edenvridge Company Information

13.17.2 Edenvridge Bacterial Vaginosis OTC Drug Product Offered

13.17.3 Edenvridge Bacterial Vaginosis OTC Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Edenvridge Main Business Overview

13.17.5 Edenvridge Latest Developments

14 Research Findings and Conclusion

Table 1. Bacterial Vaginosis OTC Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bacterial Vaginosis OTC Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pill

Table 4. Major Players of Gel

Table 5. Major Players of Cream

Table 6. Major Players of Other

Table 7. Global Bacterial Vaginosis OTC Drug Sales by Type (2017-2022) & (K Units)

Table 8. Global Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2022)

Table 9. Global Bacterial Vaginosis OTC Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Bacterial Vaginosis OTC Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Bacterial Vaginosis OTC Drug Sales by Application (2017-2022) & (K Units)

Table 13. Global Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2022)

Table 14. Global Bacterial Vaginosis OTC Drug Revenue by Application (2017-2022)

Table 15. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Bacterial Vaginosis OTC Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Bacterial Vaginosis OTC Drug Sales by Company (2020-2022) & (K Units)

Table 18. Global Bacterial Vaginosis OTC Drug Sales Market Share by Company (2020-2022)

Table 19. Global Bacterial Vaginosis OTC Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Bacterial Vaginosis OTC Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Bacterial Vaginosis OTC Drug Producing Area Distribution and Sales Area

Table 23. Players Bacterial Vaginosis OTC Drug Products Offered

Table 24. Bacterial Vaginosis OTC Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Bacterial Vaginosis OTC Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Bacterial Vaginosis OTC Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Bacterial Vaginosis OTC Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Bacterial Vaginosis OTC Drug Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Bacterial Vaginosis OTC Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Bacterial Vaginosis OTC Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Bacterial Vaginosis OTC Drug Sales by Country (2017-2022) & (K Units)

Table 36. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Bacterial Vaginosis OTC Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Bacterial Vaginosis OTC Drug Sales by Type (2017-2022) & (K Units)

Table 40. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Bacterial Vaginosis OTC Drug Sales by Application (2017-2022) & (K Units)

Table 42. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Bacterial Vaginosis OTC Drug Sales by Region (2017-2022) & (K Units)

Table 44. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Bacterial Vaginosis OTC Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Bacterial Vaginosis OTC Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Bacterial Vaginosis OTC Drug Sales by Type (2017-2022) & (K Units)

Table 48. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Bacterial Vaginosis OTC Drug Sales by Application (2017-2022) & (K Units)

Table 50. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Bacterial Vaginosis OTC Drug Sales by Country (2017-2022) & (K Units)

Table 52. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Bacterial Vaginosis OTC Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Bacterial Vaginosis OTC Drug Sales by Type (2017-2022) & (K Units)

Table 56. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Bacterial Vaginosis OTC Drug Sales by Application (2017-2022) & (K Units)

Table 58. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Bacterial Vaginosis OTC Drug

Table 68. Key Market Challenges & Risks of Bacterial Vaginosis OTC Drug

Table 69. Key Industry Trends of Bacterial Vaginosis OTC Drug

Table 70. Bacterial Vaginosis OTC Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Bacterial Vaginosis OTC Drug Distributors List

Table 73. Bacterial Vaginosis OTC Drug Customer List

Table 74. Global Bacterial Vaginosis OTC Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Bacterial Vaginosis OTC Drug Sales Market Forecast by Region

Table 76. Global Bacterial Vaginosis OTC Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Bacterial Vaginosis OTC Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Bacterial Vaginosis OTC Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Bacterial Vaginosis OTC Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Bacterial Vaginosis OTC Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Bacterial Vaginosis OTC Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Bacterial Vaginosis OTC Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Bacterial Vaginosis OTC Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Bacterial Vaginosis OTC Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Bacterial Vaginosis OTC Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Bacterial Vaginosis OTC Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Bacterial Vaginosis OTC Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Bacterial Vaginosis OTC Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Bacterial Vaginosis OTC Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Bacterial Vaginosis OTC Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Bacterial Vaginosis OTC Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Bayer Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Bayer Bacterial Vaginosis OTC Drug Product Offered

Table 96. Bayer Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Bayer Main Business

Table 98. Bayer Latest Developments

Table 99. Pfizer Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Pfizer Bacterial Vaginosis OTC Drug Product Offered

Table 101. Pfizer Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Pfizer Main Business

Table 103. Pfizer Latest Developments

Table 104. Sanofi Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Sanofi Bacterial Vaginosis OTC Drug Product Offered

Table 106. Sanofi Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Sanofi Main Business

Table 108. Sanofi Latest Developments

Table 109. Piramal Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Piramal Bacterial Vaginosis OTC Drug Product Offered

Table 111. Piramal Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Piramal Main Business

Table 113. Piramal Latest Developments

Table 114. Abbott Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Abbott Bacterial Vaginosis OTC Drug Product Offered

Table 116. Abbott Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Abbott Main Business

Table 118. Abbott Latest Developments

Table 119. Galderma Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Galderma Bacterial Vaginosis OTC Drug Product Offered

Table 121. Galderma Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Galderma Main Business

Table 123. Galderma Latest Developments

Table 124. Mission Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Mission Bacterial Vaginosis OTC Drug Product Offered

Table 126. Mission Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Mission Main Business

Table 128. Mission Latest Developments

Table 129. Alkem Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Alkem Bacterial Vaginosis OTC Drug Product Offered

Table 131. Alkem Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Alkem Main Business

Table 133. Alkem Latest Developments

Table 134. Xiuzheng Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Xiuzheng Bacterial Vaginosis OTC Drug Product Offered

Table 136. Xiuzheng Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Xiuzheng Main Business

Table 138. Xiuzheng Latest Developments

Table 139. Teva Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Teva Bacterial Vaginosis OTC Drug Product Offered

Table 141. Teva Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Teva Main Business

Table 143. Teva Latest Developments

Table 144. Perrigo Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Perrigo Bacterial Vaginosis OTC Drug Product Offered

Table 146. Perrigo Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Perrigo Main Business

Table 148. Perrigo Latest Developments

Table 149. West-Ward Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. West-Ward Bacterial Vaginosis OTC Drug Product Offered

Table 151. West-Ward Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. West-Ward Main Business

Table 153. West-Ward Latest Developments

Table 154. HPGC Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. HPGC Bacterial Vaginosis OTC Drug Product Offered

Table 156. HPGC Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. HPGC Main Business

Table 158. HPGC Latest Developments

Table 159. Yunnan Baiyao Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 160. Yunnan Baiyao Bacterial Vaginosis OTC Drug Product Offered

Table 161. Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Yunnan Baiyao Main Business

Table 163. Yunnan Baiyao Latest Developments

Table 164. Starpharma Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 165. Starpharma Bacterial Vaginosis OTC Drug Product Offered

Table 166. Starpharma Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Starpharma Main Business

Table 168. Starpharma Latest Developments

Table 169. Novel Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 170. Novel Bacterial Vaginosis OTC Drug Product Offered

Table 171. Novel Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Novel Main Business

Table 173. Novel Latest Developments

Table 174. Edenvridge Basic Information, Bacterial Vaginosis OTC Drug Manufacturing Base, Sales Area and Its Competitors

Table 175. Edenvridge Bacterial Vaginosis OTC Drug Product Offered

Table 176. Edenvridge Bacterial Vaginosis OTC Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Edenvridge Main Business

Table 178. Edenvridge Latest Developments

List of Figures

Figure 1. Picture of Bacterial Vaginosis OTC Drug

Figure 2. Bacterial Vaginosis OTC Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bacterial Vaginosis OTC Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Bacterial Vaginosis OTC Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bacterial Vaginosis OTC Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pill

Figure 10. Product Picture of Gel

Figure 11. Product Picture of Cream

Figure 12. Product Picture of Other

Figure 13. Global Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2021

Figure 14. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Type (2017-2022)

Figure 15. Bacterial Vaginosis OTC Drug Consumed in Pharmacy

Figure 16. Global Bacterial Vaginosis OTC Drug Market: Pharmacy (2017-2022) & (K Units)

Figure 17. Bacterial Vaginosis OTC Drug Consumed in On-line

Figure 18. Global Bacterial Vaginosis OTC Drug Market: On-line (2017-2022) & (K Units)

Figure 19. Bacterial Vaginosis OTC Drug Consumed in Other

Figure 20. Global Bacterial Vaginosis OTC Drug Market: Other (2017-2022) & (K Units)

Figure 21. Global Bacterial Vaginosis OTC Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Application in 2021

Figure 23. Bacterial Vaginosis OTC Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Company in 2021

Figure 25. Global Bacterial Vaginosis OTC Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Bacterial Vaginosis OTC Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Bacterial Vaginosis OTC Drug Sales 2017-2022 (K Units)

Figure 30. Americas Bacterial Vaginosis OTC Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Bacterial Vaginosis OTC Drug Sales 2017-2022 (K Units)

Figure 32. APAC Bacterial Vaginosis OTC Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Bacterial Vaginosis OTC Drug Sales 2017-2022 (K Units)

Figure 34. Europe Bacterial Vaginosis OTC Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Bacterial Vaginosis OTC Drug Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Bacterial Vaginosis OTC Drug Sales Market Share by Country in 2021

Figure 38. Americas Bacterial Vaginosis OTC Drug Revenue Market Share by Country in 2021

Figure 39. United States Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Bacterial Vaginosis OTC Drug Sales Market Share by Region in 2021

Figure 44. APAC Bacterial Vaginosis OTC Drug Revenue Market Share by Regions in 2021

Figure 45. China Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Country in 2021

Figure 52. Europe Bacterial Vaginosis OTC Drug Revenue Market Share by Country in 2021

Figure 53. Germany Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Bacterial Vaginosis OTC Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Bacterial Vaginosis OTC Drug in 2021

Figure 66. Manufacturing Process Analysis of Bacterial Vaginosis OTC Drug

Figure 67. Industry Chain Structure of Bacterial Vaginosis OTC Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles